在乳腺癌细胞模型中,阿尔法-曼戈斯和纳布-帕克利塔塞尔:通过组合疗法改善抗瘤疗效

Özge Özgen1, İdil Çetin2, Fatmahan Atalar3

  • 1Aziz Sancar Institute of Experimental Medicine, Molecular Medicine Department, Istanbul University, Istanbul Turkiye. drozgozgen@gmail.com.

概括

阿尔法-曼戈斯 (α-MG) 与纳布-帕克利塔塞尔结合,显著增强乳腺癌细胞死亡并抑制增殖. 这种组合疗法有望提高治疗效率,并有可能在临床环境中降低药物剂量.

相关概念视频

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K